Close Menu
Home » CRISPR Researchers Engineer More Efficient Cas12a Variants for Genetic, Epigenetic, Base Editing

CRISPR Researchers Engineer More Efficient Cas12a Variants for Genetic, Epigenetic, Base Editing

Feb 11, 2019
|
staff reporter

NEW YORK (GenomeWeb) – In a study published today in Nature Biotechnology, researchers in Keith Joung's lab at Massachusetts General Hospital described their efforts to engineer enhanced variants of the Cas12a nuclease that can target a wider range of protospacer adjacent motifs (PAM), have enhanced editing activity, and have reduced off-target effects.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Ah, That's What It Is

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

Billions Requested

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

What to Do

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

PNAS Papers on Heart Transplant Rejection, CAR-T Profiling, Thiopurine Toxicity Variants

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.

What's Popular?

In Gene Silencing/Gene Editing

  1. Sherlock Biosciences Developing CRISPR-Based Assay for SARS-CoV-2

    Premium

  2. Horizon Aims to Build Unique Portfolio of Gene Editing Tools While Avoiding IP Woes

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.